Pharmacologic Management of Asthma is organized by Western Schools and will be held from Jan 02, 2018 - Jan 31, 2021. This Course has been approved for a maximum of 2 Contact Hours (2 Pharm Hours).
Although asthma is a lifelong disease with no cure, it can be controlled. This course focuses on general pharmacologic interventions for managing asthma as recommended by National Asthma Education Prevention Program (NAEPP) released the Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma – Full Report 2007 (NHBLI, 2007) and the Global Initiative for Asthma (GINA) guidelines (2017), which are considered the “gold standard” for treating and managing asthma.
Asthma medicines are used to prevent and control symptoms, to reduce the frequency and severity of acute attacks, and to reverse acute airflow obstruction. Asthma medicines are grouped into two general classes: quick-relief (rescue) and long-term control. Asthma therapy should match the severity of asthma symptoms. Persons classified as having intermittent asthma who are experiencing mild symptoms and those with exercise-induced asthma should be treated with quick-relief medication on an as-needed basis. Those with persistent symptoms should additionally receive a long-term controller medication or medications (intended to be used daily) for asthma control.
• Describe the role of quick-relief medications in the treatment of asthma and their side effects.
• Describe long-term control medications in the treatment of asthma and their side effects.
• Discuss the stepwise approach to medication therapy based on asthma severity levels.
• Describe the vaccines recommended for persons with asthma.
• Describe the different techniques for asthma medication administration.
Clinical Pharmacology, Pulmonary Medicine, Asthma Clinical Immunology